Find uplifting stories about heroes, innovations, and solutions
4748 results for "cancer vaccine"
Since the HPV vaccine became available in 2006, cervical cancer rates have dropped 27% among young American women, with some states seeing reductions over 50%. Every 10% increase in vaccination rates translates to nearly 12% fewer cancer cases.
A personalized mRNA vaccine helped 11 women with aggressive breast cancer stay cancer-free for up to six years. The groundbreaking treatment trained their immune systems to recognize and fight cancer cells using their own tumor's genetic code.
For the first time in history, cervical cancer deaths fell to zero among women aged 20-24 in England. The breakthrough proves we can actually prevent cancer through vaccination.
Scientists at Johns Hopkins developed a vaccine that may prevent pancreatic cancer before it starts, triggering lasting immune responses in 90% of high-risk patients. None of the 20 participants developed cancer during the study, and some saw their precancerous cysts shrink or disappear.
A groundbreaking cancer vaccine has nearly eliminated cervical cancer in young women, with doctors reporting they rarely see the disease in patients under 25 anymore. The success story reveals how vaccines can prevent cancer and save lives.
A groundbreaking breast cancer vaccine has received patent approval in South Korea, marking a major step toward preventing the world's most common cancer in women. The vaccine showed promising safety results and immune responses in 74% of trial participants.
A groundbreaking 18-year study from Sweden shows the HPV vaccine provides lasting protection against cervical cancer, with no signs of weakening over time. Nearly a million women participated in research that could help eliminate cervical cancer as a public health threat.
A personalized mRNA cancer vaccine for melanoma is showing clinical success, offering hope that cancer treatment breakthroughs might help rebuild public confidence in vaccine technology. The same mRNA platform that powered COVID-19 vaccines is now being adapted to fight cancer.
A woman's dog detected her breast cancer by pressing his nose to a lump on her chest. Now she's part of a groundbreaking vaccine trial that could prevent aggressive breast cancer from returning.
A groundbreaking personalized mRNA cancer vaccine has passed its first major clinical trial, marking a milestone in the fight against cancer. The treatment prevented melanoma from returning in patients after surgery, offering new hope for thousands facing the disease.
Cervical cancer is one of the most preventable cancers, yet it claims thousands of lives each year. A safe, proven vaccine could change that story completely.
A personalized cancer vaccine has stopped deadly skin cancer from returning in patients, marking what scientists call a pivotal breakthrough in treatment. The experimental jab uses the same mRNA technology that powered COVID vaccines to target cancer cells.
A new vaccine prevented pancreatic cancer from developing in 20 high-risk patients, with 90% showing lasting immune responses. For the first time, researchers have found a way to intercept one of the deadliest cancers before it starts.
After political backlash threatened to derail cancer research, mRNA vaccines are delivering real hope to patients with deadly diseases like pancreatic cancer. New funding and positive trial results suggest the technology could save thousands of lives.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, helped patients live twice as long as usual in a groundbreaking trial. One patient remains cancer-free nearly five years later.
Young women who get the HPV vaccine in their early teens have virtually no risk of dying from cervical cancer before age 30. This groundbreaking research proves the vaccine is even more life-saving than scientists initially believed.
For the first time ever, zero women aged 20-24 died from cervical cancer in the UK over a five-year period, thanks to routine HPV vaccination. Without the vaccine, 23 deaths would have been expected during that time.
For the first time ever, zero women in their early 20s died from cervical cancer in England over a four-year period. Scientists credit the HPV vaccine with reducing cervical cancer death risk before age 30 to "effectively zero."
Young women vaccinated against HPV at age 12-13 now have close to zero risk of dying from cervical cancer before 30. A landmark study from England shows the vaccine has already saved around 200 lives since 2008.
A personalized DNA vaccine for glioblastoma, one of the deadliest brain cancers, doubled survival rates in early trials and kept one patient cancer-free for nearly five years. The vaccine trains each patient's immune system to recognize up to 40 unique cancer proteins, making it harder for tumors to hide.
Showing 20 of 4748